BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

CAREDX — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

CAREDX

via CURA STRATEGIES

3rd Quarter (July 1 - Sep 30) · 2023Posted Nov 7, 2023Filing document ↗LDA record ↗

Income$36Kfee reported

Client

Name: CAREDX
Description: molecular diagnostics company
Location: California · United States of America

Registrant

Firm: CURA STRATEGIES
Description: Public relations/advocacy firm
Location: Arlington, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
Medicare/Insurance coverage for innovative diagnostic testing
LobbyistsSCOTT C LEEZER · MICHAEL LISOWSKI · PATRICK MEADE
Covered position (SCOTT C LEEZER): Aide to Senator Richard Durbin
Covered position (MICHAEL LISOWSKI): Aide to Rep. Joe Heck
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.